CIPO trademark

BLEXVYCTRA

FiledCIPOWord markClass 5

"BLEXVYCTRA" is a word mark owned by Johnson & Johnson, filed at the CIPO on October 8, 2026. It is filed and waiting for examination and covers class 5 (Pharmaceuticals).

View Johnson & Johnson portfolioGet this data via the API
Official CIPO record
BLEXVYCTRA
Word mark as filed with the CIPO
Status
Filed
Since October 8, 2026
Filed
October 8, 2026
Registered
Not yet
Expires
Not recorded
Application no.
2506555
Registration no.
Not yet
Office
CIPO
Canadian Intellectual Property Office
Mark type
Word mark
1 class
Ownership

Who owns BLEXVYCTRA

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Johnson & Johnson

JNJ · United States

11,056 trademarks in the portfolioView company

Representative

Gowling WLG (Canada) LLP

Gowling WLG (Canada) LLP

Goods and services

What the mark covers

The products and services BLEXVYCTRA is filed for, grouped by Nice class.

  • Human pharmaceutical preparations for the prevention and treatment of auto-immune diseases, cardiovascular diseases, pulmonary hypertension, pulmonary arterial hypertension, gastro-intestinal diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, cerebrovascular diseases; human pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis and anemia; human pharmaceutical preparations for the prevention and treatment of neurological diseases, namely Alzheimer's, Huntington's disease, multiple sclerosis, and cerebral palsy; human pharmaceutical preparations for the prevention and treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, and schizophrenia; human pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases, psoriasis; Human pharmaceutical preparations for the prevention and treatment of hemolytic disease of the newborn; human pharmaceuticals preparations, namely anxiolytic medications, anti-virals, anti-inflammatories, anti-infectives, namely, antibacterials and antifungals, anti-allergic medications; human pharmaceutical preparations for the relief of pain

History

What has happened so far

Steps recorded by the CIPO, newest first.

  1. Formalized
  2. Created
  3. Filed
FAQ

About BLEXVYCTRA

Who owns the trademark "BLEXVYCTRA"?

The CIPO trademark "BLEXVYCTRA" (application 2506555) is owned by Johnson & Johnson.

What is the status of "BLEXVYCTRA"?

Its status at the CIPO is: filed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull BLEXVYCTRA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_01a13b99-0d63-76db-b481-aeb4e4bd671e
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a13b99-0d63-76db-b481-aeb4e4bd671e",
  "object": "trademark",
  "mark_text": "BLEXVYCTRA",
  "status": {
    "primary": "pending",
    "stage": "filed"
  },
  "office_code": "CA",
  "application_number": "2506555",
  "filing_date": "2026-10-08",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "JOHNSON & JOHNSON",
      "entity_id": "ent_019eb7ba-67fc-717e-bcfd-996931fa9380"
    }
  ]
}